Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$40.5M |
| 2 |
S&P Global
SPGI
|
+$30.2M |
| 3 |
Medtronic
MDT
|
+$25.3M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$23.2M |
| 5 |
Northrop Grumman
NOC
|
+$20.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$63.7M |
| 2 |
Conagra Brands
CAG
|
+$20.3M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$20M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$18.2M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$15.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 13.74% |
| 2 | Healthcare | 12.91% |
| 3 | Technology | 11.18% |
| 4 | Consumer Discretionary | 11.04% |
| 5 | Industrials | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
876
Amdocs
DOX
$4.61B
| $466K | 0.02% |
8,000
-500
| -6% | -$29.5K |
2015 Q4
4 quarters
|
|
877
Darling Ingredients
DAR
$8.58B
| $465K | 0.02% |
36,046
-60,019
| -62% | -$813K |
2015 Q4
4 quarters
|
|
878
First Financial Bancorp
FFBC
$3.42B
| $465K | 0.02% |
+16,339
| New | +$403K |
2016 Q4
0 quarters
|
|
879
NetApp
NTAP
$36.5B
| $465K | 0.02% |
13,186
-17,243
| -57% | -$603K |
2016 Q3
1 quarter
|
|
|
CSC
880
DELISTED
Computer Sciences
CSC
| $464K | 0.02% |
7,802
+2,481
| +47% | +$143K |
2015 Q1
7 quarters
|
|
881
Kyntra Bio
KYNB
$14.5M
| $462K | 0.02% |
+863
| New | +$431K |
2016 Q4
0 quarters
|
|
882
Novartis
NVS
$303B
| $462K | 0.02% |
+7,084
| New | +$460K |
2016 Q4
0 quarters
|
|
883
United Parks & Resorts
PRKS
$1.82B
| $461K | 0.02% |
+24,372
| New | +$399K |
2016 Q4
0 quarters
|
|
|
NATI
884
DELISTED
National Instruments Corp
NATI
| $461K | 0.02% |
+14,947
| New | +$435K |
2016 Q4
0 quarters
|
|
885
Radian Group
RDN
$4.65B
| $460K | 0.02% |
+25,600
| New | +$384K |
2016 Q4
0 quarters
|
|
886
Rayonier Advanced Materials
RYAM
$371M
| $460K | 0.02% |
29,779
+8,436
| +40% | +$118K |
2016 Q3
1 quarter
|
|
887
MSCI
MSCI
$46.6B
| $458K | 0.02% |
5,817
-858
| -13% | -$69.1K |
2015 Q2
6 quarters
|
|
888
Cleveland-Cliffs
CLF
$7.46B
| $456K | 0.02% |
54,200
-5,842
| -10% | -$44K |
2016 Q3
1 quarter
|
|
889
Kaiser Aluminum
KALU
$1.81B
| $454K | 0.02% |
+5,849
| New | +$467K |
2016 Q4
0 quarters
|
|
890
Preferred Bank
PFBC
$1.23B
| $454K | 0.02% |
+8,669
| New | +$367K |
2016 Q4
0 quarters
|
|
891
PTC Therapeutics
PTCT
$5.29B
| $454K | 0.02% |
41,643
+15,165
| +57% | +$159K |
2016 Q3
1 quarter
|
|
|
CSII
892
DELISTED
Cardiovascular Systems, Inc.
CSII
| $454K | 0.02% |
+18,768
| New | +$461K |
2016 Q4
0 quarters
|
|
893
WSFS Financial
WSFS
$4.04B
| $453K | 0.02% |
+9,770
| New | +$393K |
2016 Q4
0 quarters
|
|
894
Buckle
BKE
$2.26B
| $451K | 0.02% |
19,765
+10,045
| +103% | +$231K |
2016 Q3
1 quarter
|
|
895
LSB Industries
LXU
$840M
| $451K | 0.02% |
69,694
+43,681
| +168% | +$253K |
2016 Q2
2 quarters
|
|
896
MYR Group
MYRG
$4.34B
| $451K | 0.02% |
+11,970
| New | +$412K |
2016 Q4
0 quarters
|
|
897
Altisource Portfolio Solutions
ASPS
$62.9M
| $450K | 0.02% |
+2,115
| New | +$472K |
2016 Q4
0 quarters
|
|
898
Marathon Petroleum
MPC
$112B
| $450K | 0.02% |
8,942
-104,197
| -92% | -$4.73M |
2014 Q4
8 quarters
|
|
899
Alpha and Omega Semiconductor
AOSL
$925M
| $449K | 0.02% |
+21,116
| New | +$456K |
2016 Q4
0 quarters
|
|
900
Wingstop
WING
$4.31B
| $449K | 0.02% |
+15,190
| New | +$446K |
2016 Q4
0 quarters
|
|
Similar funds
Squarepoint's Q4 2016 Portfolio in Review
As of Q4 2016, Squarepoint held 2,060 positions worth $2.44B, up 62% from $1.51B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Squarepoint deployed $913M of net new capital in Q4 2016, opening 1,079 new positions and adding to 424 existing holdings. Its largest new stake was S&P Global: 252,484 shares worth $27.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 14% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Conagra Brands, an estimated $20.3M trimmed.
- Squarepoint's largest Q4 2016 buy was S&P Global: 252,484 shares worth $27.2M.
- Squarepoint added most to iShares China Large-Cap ETF in Q4 2016, an estimated $40.5M increase.
- Squarepoint's biggest Q4 2016 reduction was Conagra Brands, cutting an estimated $20.3M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q4 2016, selling an estimated $63.7M.
- Squarepoint's ten largest holdings make up 9.6% of its $2.44B portfolio in Q4 2016.
- Squarepoint opened 1,079 new positions and closed 329 in Q4 2016.
- Squarepoint's portfolio value rose 62% quarter-over-quarter to $2.44B.
Based on Squarepoint's 13F filing for Q4 2016, filed 14 Feb 2017.